Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Application (Cell Line Engineering & Genetic Engineering), End User (Research Centers, Pharmaceutical & Biotechnology Companies, CROs) - Analysis & Forecast 2019-2030

Report ID : 5  |  Published Date : Jan 2019  |  Pages : 150  |  Region : Global  |  Report Code : BT-01




Genome Editing/Genome Engineering Market Overview and Introduction

The global genome editing market was valued at over US$ 3.0 Bn. in 2017 and is expected to grow at a double digit CAGR during the forecasted period.The global genome editing/genome engineering market is segmented by application, technology, end user, and region.

Genome Editing/Genome Engineering technique are used for insertion, deletion or modify genome of a microorganism. Techniques like TALEN, CRISPR (clustered regularly interspaced palindromic repeat) and other technique are widely used in genome editing/engineering process. CRISPR-Cas9 technique is one of the most widely preferred technologies in genome editing.

The global genome editing/genome engineering market is driven by technological advancements in the genomics, rising number of cancer patients, and increasing funding by government & private players in the genomics are major factors driving the market. However, ethical issue related to genome editing/genome engineering is likely to restrain the market to certain extent.

Genome Editing/Genome Engineering Market by Technology 

Based on technology, the market is segmented into TALEN, CRISPR, ZFN and other technologies. The CRISPR technologies market is estimated to account for the largest share of the global genome editing/genome engineering market. The large share of this segment can be attributed to growing acceptance of the technology, government funding to promote genome research projects and focus to produce genetically modified crops.

Genome Editing/Genome Engineering by End Users 

On the basis of end user, the Genome Editing/Genome Engineering Market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes Contract Research Organizations, and other end users. The Pharmaceutical & Biotechnology Companies segment is estimated to account for the largest share of the genome editing/genome engineering market. Increasing number of cancer cases globally and need for genome research are driving the growth of end-user segment.

Genome Editing/Genome Engineering by Application

On the basis application the market is segmented into cell line engineering, genetic engineering and other applications. Cell line engineering is expected to account for the largest share of the segment. Factors such as, growing focus on stem cell technology and government & private funding in the research area are likely to drive the market for genome editing/genome engineering market.

Genome Editing/Genome Engineering Market by Regions 

The global genome editing/genome engineering market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW).  North America dominated the market of genome editing/genome engineering, followed by Europe and Asia Pacific. North America will continue to dominate the global genome editing/genome engineering market in the forecast period owing to factors such as growing research on stem cells and cell lines for cancer therapy, rising use of genetically modified crops and highly developed healthcare system and funding from government and private institute. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered at China, India, and Japan. Factors such as the rising focus of major players in emerging Asian countries and government support are driving the growth of the genome editing/genome engineering market in this region. However, Ethical issue related genome editing/genome engineering products and lack of skilled professionals may restrain market growth to a certain extent.

Genome Editing/Genome Engineering Market Prominent Players 

The prominent players in the global genome editing/genome engineering market are Thermo Fisher Scientific (US), Lonza Group (Switzerland), Merck (Germany), Horizon Discovery Group (UK), Integrated DNA Technologies (US), New England Biolabs (US), GenScript (US), Sangamo BioSciences (US),  OriGene Technologies (US), Transposagen Biopharmaceuticals (US), Editas Medicine (US), and CRISPR Therapeutics (Switzerland)., among others.

Table of Contents

  1. INTRODUCTION
    1. Market Definition
    2. Market Ecosystem
      1.   Market Classification
      2.   Geographic Scope
      3.   Years Considered for the Study
        1. Historical Years – 2016 & 2017
        2. Base Year – 2018
        3. Forecasted Years – 2019 to 2030
    3. Currency Used for the Study
    4. Report Beneficiary List
  2. RESEARCH METHODOLOGY
    1. Research Framework
    2. Data Collection Technique
    3. Data Sources
      1.  Secondary Sources
      2.  Primary Sources
    4. Market Estimation Methodology
      1.   Bottoms Up Approach
      2.   Top Down Approach
    5. Data Validation and Triangulation
      1.   Market Forecasting Model
      2.   Limitations of the Study
      3.   Assumptions of the Study
  3. ABSTRACT OF THE STUDY
  4. MARKET DYNAMICS ASSESMENT
    1. Overview
    2. Drivers
    3. Barriers/Challenges
    4. Opportunities
  5. UNIQUE SELLING PROPOSITIONS (USPs)
    1. Technological Advancement
    2.   Initiatives Assessment: Government & Private Bodies
  6. GLOBAL GENOME EDITING/GENOME ENGINEERING MARKET - ANALYSIS & FORECAST, BY TECHNOLOGY
    1. Introduction & Definition
    2. TALEN (Transcription activator-like effector nucleases)
    3. CRISPR 
    4. ZFN
    5. Other Technologies
  7. GLOBAL GENOME EDITING/GENOME ENGINEERING MARKET - ANALYSIS & FORECAST, BY APPLICATION
    1. Introduction 
    2. Genetic  Engineering  
    3. Cell Line Engineering
    4. Other Applications
  8. GLOBAL GENOME EDITING/GENOME ENGINEERING MARKET - ANALYSIS & FORECAST, BY END USER
    1. Introduction 
    2. Academic Institutes & Research Centers 
    3. Contract Research Organization 
    4. Pharmaceutical & Biotechnology Companies 
    5. Other End User
  9. GLOBAL GENOME EDITING/GENOME ENGINEERING MARKET - ANALYSIS & FORECAST, BY REGION
    1.     North America Genome Editing/Genome Engineering Market
      1.   North America Genome Editing/Genome Engineering Market, By Country
        1.  US
        2.  Canada
      2. North America Genome Editing/Genome Engineering Market Analysis & Forecast, By Technology
      3. North America Genome Editing/Genome Engineering Market Analysis & Forecast, By Application
      4. North America Genome Editing/Genome Engineering Market Analysis & Forecast, By End User
    2. Europe Genome Editing/Genome Engineering Market
      1. Europe Genome Editing/Genome Engineering Market, By Country/Region
        1. Germany
        2. U.K
        3. France
        4. Rest of Europe (ROE)
      2. Europe Genome Editing/Genome Engineering Market Analysis & Forecast, By Technology
      3. Europe Genome Editing/Genome Engineering Market Analysis & Forecast, By Application
      4. Europe Genome Editing/Genome Engineering Market Analysis & Forecast, By End User
    3. Asia Pacific Genome Editing/Genome Engineering Market
      1. Asia Pacific Genome Editing/Genome Engineering Market, By Country/Region
        1. China
        2. Japan
        3. India
        4. Rest of Asia Pacific (RoAPAC)
      2. Asia Pacific Genome Editing/Genome Engineering Market Analysis & Forecast, By Technology
      3. Asia Pacific Genome Editing/Genome Engineering Market Analysis & Forecast, By Application
      4. Asia Pacific Genome Editing/Genome Engineering Market Analysis & Forecast, By End User
    4.    Rest of the World (ROW) Genome Editing/Genome Engineering Market
      1. Rest of the World Genome Editing/Genome Engineering Market, By Country/ Region
        1.  Latin America
        2.  Middle East & Africa
      2. Rest of the World Genome Editing/Genome Engineering Market Analysis & Forecast, By Technology
      3. Rest of the World Genome Editing/Genome Engineering Market Analysis & Forecast, By Application
      4. Rest of the World Genome Editing/Genome Engineering Market Analysis & Forecast, By End User
  10. COMPETETIVE LANDSCAPE
    1. Market Share Analysis (2018)
    2. Key Strategies Assessment
      1. New Product Launches
      2. Merger & Acquisitions
      3. Agreements, Collaborations, & Partnerships
      4. Expansions
      5. Other Strategies
  11. COMPANY PROFILES (Business Overview, Products/Services Offered, Financial Performance, R&D Intensity, Marketing & Sales Intensity, Recent Developments, Analyst Corner)*
    1.    Merck Group
    2.    Horizon Discovery Group
    3.    Genescript
    4.    Thermo Fisher Scientific  
    5.    Lonza
    6.    Origene Technologies
    7.    New England Biolabs
    8.    Sangamo Bioscience
    9.     Editas Medicine, Inc.
    10. CRISPR Therapeutics AG (*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain)
  12. APPENDIX
    1. Questionnaire
    2. Primary Interviews Transcripts
    3.    Customization Options
    4. Profile of the Author